中医药通过肺淋巴管系统干预间质性肺疾病的研究进展
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

上海市重大危重医疗事件中西医协同响应与干预平台建设项目(ZY2018-2020-FWTX-7004)


Research Progress of Intervention of Traditional Chinese Medicine on Interstitial Lung Disease through Pulmonary Lymphatic System
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    间质性肺疾病(ILD)是一种以弥漫性肺实质的炎症和肺纤维化改变为特征的疾病。淋巴管系统在炎症和纤维化疾病中发挥重要作用。已知在炎症性疾病和纤维化疾病中淋巴管系统具有重要功能。但在间质性肺疾病中淋巴管系统作用的相关研究较少,随着科技的进步,逐渐发现了间质性肺疾病中肺淋巴管系统发挥作用的重要机制。且近年来运用中药疗法干预淋巴管系统来治疗疾病成为研究热点。现将基于肺淋巴管系统与间质性肺疾病中的相关性来探讨中医药对间质性肺疾病的干预作用。

    Abstract:

    Interstitial lung disease(ILD) is characterized by diffuse parenchymal lung inflammation and pulmonary fibrosis.The lymphatic system plays an important role in inflammation and fibrosis.The lymphatic system is known to have important functions in inflammatory and fibrotic diseases.However, there are few related studies on the role of the lymphatic system in interstitial lung diseases.With the advancement of science and technology, the important mechanism of the role of the pulmonary lymphatic system in interstitial lung diseases has been gradually discovered.In recent years,the use of Chinese medical therapy to intervene the lymphatic system to treat diseases has become a research hotspot.This paper will discuss the intervention effect of traditional Chinese medicine on ILD based on the correlation between the pulmonary lymphatic system and ILD.

    参考文献
    相似文献
    引证文献
引用本文

黄怡,石怡,木其尔,陈伟.中医药通过肺淋巴管系统干预间质性肺疾病的研究进展[J].世界中医药,2023,(03).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-05-10
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-04-11
  • 出版日期:
文章二维码